University of Utah Wins $16M for Molecular and Translational Science Center | GenomeWeb

NEW YORK (GenomeWeb News) – The University of Utah Department of Medicine has been awarded $16 million from the National Heart, Lung, and Blood Institute to fund interdisciplinary studies that delve into the molecular and cellular causes of blood clots.

The funding will support the University's Molecular Medicine Translational Research Center in Thrombosis, which will use the funding for basic and clinical science efforts to discover and test new diagnostic, preventative, and therapeutic interventions for thrombosis, the university said yesterday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Startup companies are taking on personalized medicine, CNET reports.

Bruce Booth writes at Life Sci VC that biotech clusters like Boston and San Francisco are getting even more consolidated.

The Verge speaks with Mark and Scott Kelly, who are the subjects of NASA's Twin Study.

In Genome Biology this week: genes linked to Hirschsprung disease, structural variant patterns in autism, and more.